Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)
Clinical trial NCT05111743 · COMPLETED
Trial details
- NCT number
- NCT05111743
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-12-18
- Enrollment
- 9261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.